For: | Liu Y, Lu CY, Zheng Y, Zhang YM, Qian LL, Li KL, Tse G, Wang RX, Liu T. Role of angiotensin receptor-neprilysin inhibitor in diabetic complications. World J Diabetes 2024; 15(5): 867-875 [PMID: 38766431 DOI: 10.4239/wjd.v15.i5.867] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v15/i5/867.htm |
Number | Citing Articles |
1 |
Shikha Thakur, Sandhya Chahal, Madhav S. Jadhav, Priyanka Mohanty, Anil Bhanudas Gaikwad, Jayant Sindhu, Hemant R. Jadhav. Design and development of chromene-3-carboxylate derivatives as antidiabetic agents: Exploring the antidiabetic potential via dual inhibition of angiotensin II type 1 receptor and neprilysin enzyme. European Journal of Medicinal Chemistry 2025; 293: 117705 doi: 10.1016/j.ejmech.2025.117705
|
2 |
Tingting Li, Qiumei Lin, Danni Zhou, Yi Jiang, Sheng Chen, Ruoqing Li. Single-cell Transcriptomics, Web-based Systems Pharmacology and Integrated Transcriptomics Network Analysis Identified Diagnostic Targets and Drug Candidates for Type 2 Diabetes. Endocrine, Metabolic & Immune Disorders - Drug Targets 2025; 25(9): 732 doi: 10.2174/0118715303331820240820072804
|